|
Successfully bringing biosimilars to market can be challenging. Learn to tackle the technical obstacles to the development and marketing approval for biosimilars at the 2018 PDA Biosimilars Workshop, Sept. 26-27!
Over two days, noted industry experts and speakers from the U.S. FDA, EMA, Health Canada, and the Medicines Evaluation Board (MEB) in The Netherlands will share practical approaches to avoid the pitfalls frequently encountered during biosimilar candidate development.
Through plenary and breakout sessions, gain valuable insight into a broad range of topics, including:
- The Regulatory Perspective on Biosimilar Marketing Applications
- The Trapeze and The Trap Door: Navigating High-Level Technical Challenges in Biosimilar Development
- Demonstrating Analytical Similarity: The Role of Statistics Tools
Throughout the Workshop, successful case studies and practical examples will be used to illustrate how analytical similarity can be demonstrated and how practical control strategies can be developed.
If your company is involved in biosimilar development, then you can’t afford to miss this informative Workshop!
Register by Jul. 16 and save up to $200!
|
